Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid.
暂无分享,去创建一个
L. Fallowfield | C. Cleeland | D. Patrick | S. Novello | F. Goldwasser | D. Henry | S. Vadhan-Raj | V. Hungria | Y. Qian | K. Chung | A. Feng | R. von Moos | H. Yeh